A common uptake system for serotonin and dopamine in human platelets.

Kinetic and pharmacologic properties of uptake of serotonin and dopamine by normal human platelets have been investigated to test whether platelets can be employed as a model system for the reuptake of serotonin and dopamine in brain. Uptake of serotonin into platelets closely resembles reuptake of serotonin into serotonergic neurons. In contrast, uptake of dopamine into platelets appears to be mediated inefficiently via the specific serotonin uptake mechanism, based upon several lines of evidence. Serotonin and dopamine compete with each other, Antidepressant drugs, which are competitive inhibitors of uptake of both of these neurotransmitters, act at the same concentration of drug despite large differences in the Km values. Serotonin antagonists inhibit both serotonin and dopamine uptake. Finally, a serotonin-specific uptake inhibitor (fluoxetine) blocks dopamine, as well as serotonin, uptake.

[1]  E. Tukiainen,et al.  Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients , 1976, Nature.

[2]  M. Paasonen.  Release of 5‐hydroxytryptamine from blood platelets * , 1965, The Journal of pharmacy and pharmacology.

[3]  S. Snyder,et al.  Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. , 1970, The Journal of pharmacology and experimental therapeutics.

[4]  H. M. Solomon,et al.  The accumulation and metabolism of dopamine by the human platelet , 1970, Clinical pharmacology and therapeutics.

[5]  G. Omenn,et al.  Platelet uptake of serotonin and dopamine in Huntington disease , 1978, Neurology.

[6]  R. O'brien,et al.  Accumulation of dopamine by blood platelets from normal subjects and parkinsonian patients under treatment with l‐DOPA , 1970, British journal of pharmacology.

[7]  G. Born,et al.  Uptake, metabolism and release of [3H]‐adrenaline by human platelets , 1970, British journal of pharmacology.

[8]  K. Fuxe,et al.  The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. , 1971, Neuropharmacology.

[9]  P. Molinoff,et al.  Occurrence, transport, and storage of octopamine in human thrombocytes , 1975, Clinical pharmacology and therapeutics.

[10]  L. Tuomisto,et al.  Dopamine uptake in striatal and hypothalamic synaptosomes: conformational selectivity of the inhibition. , 1974, European journal of pharmacology.

[11]  S. M. Bayer,et al.  A comparison of the serotonin and ATP content in platelets from subjects with Down's syndrome. , 1974, Biochemical medicine.

[12]  D. Wong,et al.  A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. , 1974, Life sciences.

[13]  J. Axelrod.  THE METABOLISM, STORAGE, AND RELEASE OF CATECHOLAMINES. , 1965, Recent progress in hormone research.

[14]  H. Weiss.  Platelet Physiology and Abnormalities of Platelet Function , 1975 .

[15]  M. Sandler,et al.  5-Hydroxytryptamine deficiency in phenylketonuria. , 1957, Lancet.

[16]  G. Omenn,et al.  Comparisons of serotonin uptake by blood platelets and brain synaptosomes , 1978, Brain Research.

[17]  S. Snyder,et al.  Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates. , 1969, The Journal of pharmacology and experimental therapeutics.

[18]  J. Tuomisto.  A new modification for studying 5‐HT uptake by blood platelets: a re‐evaluation of tricyclic antidepressants as uptake inhibitors * , 1974, The Journal of pharmacy and pharmacology.

[19]  K. Starke.  The mechanism of neuronal and extraneuronal transport of catecholamines D. M. Paton (ed) Raven Press, New York (1976), 370 pp., $27.50 , 1976, Neuroscience.

[20]  J. Raynaud,et al.  Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum , 1974, The Journal of pharmacy and pharmacology.

[21]  M. Aminoff,et al.  Plasma uptake of dopamine and 5-hydroxytryptamine and plasma-catecholamine levels in patients with Huntington's chorea. , 1974, Lancet.

[22]  D. Murphy,et al.  Serotonin and platelet function in Duchenne muscular dystrophy. , 1973, Archives of neurology.

[23]  R. Butterworth,et al.  Uptake and efflux of 14C‐dopamine in platelets , 1975, Neurology.

[24]  T. Tschopp,et al.  Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism. , 1974, The Journal of clinical investigation.

[25]  S. Snyder,et al.  Catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecificity in different areas. , 1969, The Journal of pharmacology and experimental therapeutics.

[26]  D. Wong,et al.  Kinetics of serotonin accumulation into synaptosomes of rat brain--effects of amphetamine and chloroamphetamines. , 1973, Biochemical pharmacology.

[27]  D. Murphy,et al.  Down's Syndrome: Transport, Storage, and Metabolism of Serotonin in Blood Platelets , 1972, Pediatric Research.

[28]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[29]  J. Sneddon,et al.  Blood platelets as a model for monoamine-containing neurones. , 1973, Progress in neurobiology.

[30]  G. Omenn.  Serotonin in Down's Syndrome , 1975 .

[31]  I. Hanin,et al.  Can the human blood platelet be used as a model for the cholinergic nerve ending , 1972 .

[32]  R. Miller,et al.  DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY , 1974, Journal of neurochemistry.

[33]  R. O'brien,et al.  Abnormalities of 5‐hydroxytryptamine uptake and binding by blood platelets from children with Down's syndrome , 1971, The Journal of physiology.

[34]  L. Iversen.  The Uptake and Storage of Noradrenaline in Sympathetic Nerves , 1967 .

[35]  R. O'brien,et al.  The metabolism of 5-hydroxytryptamine by blood platelets from children with mongolism. , 1973, Biochemical pharmacology.

[36]  A. Pletscher.  Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. , 1968, British journal of pharmacology and chemotherapy.